Shandong Xinhua Pharmaceutical Co Ltd is a CN-based company operating in Pharmaceuticals industry. The company is headquartered in Zibo, Shandong and currently employs 7,296 full-time employees. Shandong Xinhua Pharmaceutical Co Ltd is a China-based company mainly engaged in the development, manufacturing and sales of chemical raw materials, pharmaceutical preparations and chemical products. The firm operates three segments. The Chemical Raw Materials segment is mainly engaged in the development, manufacturing and sales of raw materials for antipyretics and analgesics such as caffeine series, ibuprofen series, aspirin series, dopamine series, barbiturates and pipemidic acid. The Pharmaceutical Preparations segment is mainly engaged in the development, manufacturing and sales of tablets, injections and capsules such as pipemidic acid tablets, aminopyrine and nimodipine tablets. The Pharmaceutical Intermediates and Other Products segment is mainly engaged in the development, manufacturing and sales of pharmaceutical intermediates and other products. The firm mainly operates its business in the domestic market and overseas markets such as the Americas and Europe.
Shandong Xinhua Pharmaceutical Company Limited의 매출은 부문 또는 지역별로 어떻게 나뉘나요?
Shandong Xinhua Pharmaceutical Company Limited 주요 수익원은 Preparation이며, 최신 수익 발표에서 수익은 4,072,208,527입니다. 지역별로는 China (including Hong Kong)이 Shandong Xinhua Pharmaceutical Company Limited의 주요 시장이며, 수익은 6,332,209,258입니다.
Shandong Xinhua Pharmaceutical Company Limited은 수익성이 있나요?
예, 최신 재무제표에 따르면 Shandong Xinhua Pharmaceutical Company Limited의 순이익은 $470입니다.
Shandong Xinhua Pharmaceutical Company Limited에 부채가 있나요?
예, Shandong Xinhua Pharmaceutical Company Limited의 부채는 4,028입니다.
Shandong Xinhua Pharmaceutical Company Limited의 발행 주식은 몇 주인가요?
Shandong Xinhua Pharmaceutical Company Limited의 총 발행 주식은 682.4주입니다.